ClassID:

94154

C07D211/24 - CPC Classification

Classification description:

Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached

Recent Application in this class:
#1
20260055083
2026-02-26

APOL1 INHIBITORS AND METHODS OF USE

#2
20260001843
2026-01-01

SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

#3
20250368595
2025-12-04

NOVEL MOLECULES

#4
20250250233
2025-08-07

PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF PRIDOPIDINE

#5
20250214935
2025-07-03

METHOD FOR PRODUCING ARYL ESTER-CONTAINING CARBOXYLIC ACID AND METHOD FOR PRODUCING CATIONIC LIPID

#6
20240174610
2024-05-30

Substituted piperidine compound and use thereof

#7
20230357208
2023-11-09

MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS

#8
20230051589
2023-02-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#9
20220370357
2022-11-24

IONIZABLE LIPIDS AND NANOPARTICLE COMPOSITIONS THEREOF

#10
20220267260
2022-08-25

COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS

#11
20220169605
2022-06-02

Substituted sulfonylurea derivatives

#12
20220162197
2022-05-26

MYST family histone acetyltransferase inhibitors

#13
20220106323
2022-04-07

SPIROCYCLIC ROR-GAMMA MODULATORS

#14
20220081399
2022-03-17

SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

#15
20220023280
2022-01-27

ANALOGS OF PRIDOPIDINE, THEIR PREPARATION AND USE

#16
20210053976
2021-02-25

Spirocyclic ROR-gamma modulators

#17
20200331850
2020-10-22

Sulfonamide carboxamide compounds

#18
20200115399
2020-04-16

Substituted piperidine compound and use thereof

#19
20200030308
2020-01-30

Analogs of pridopidine, their preparation and use

#20
20190263843
2019-08-29

Substituted piperidine compound and use thereof

#21
20190030016
2019-01-31

Analogs of pridopidine, their preparation and use

#22
20190015401
2019-01-17

Deuterated analogs of pridopidine useful as dopaminergic stabilizers

#23
20180235950
2018-08-23

DEUTERATED ANALOGS OF PRIDOPIDINE USEFUL AS DOPAMINERGIC STABILIZERS

#24
20170226137
2017-08-10

Substituted piperidine compound and use thereof

#25
20170022158
2017-01-26

Process for preparing pridopidine

#26
20160243098
2016-08-25

Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

#27
20160176821
2016-06-23

L-tartrate salt of pridopidine

#28
20150374677
2015-12-31

Analogs of pridopidine, their preparation and use

#29
20150209344
2015-07-30

Hydrobromide salt of pridopidine

#30
20140315951
2014-10-23

Polymorphic form of pridopidine hydrochloride

#31
20140128368
2014-05-08

Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment

#32
20140018371
2014-01-16

Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto

#33
20130150406
2013-06-13

Hydrobromide salt of pridopidine

#34
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#35
20130040932
2013-02-14

SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

#36
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#37
20120172358
2012-07-05

GPCR Agonists

#38
20120149694
2012-06-14

Substituted piperidines

#39
20120129883
2012-05-24

Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor

#40
20120077812
2012-03-29

BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS

#41
20120046276
2012-02-23

Tuberculosis treatment using pleuromutilin derivatives

#42
20110313144
2011-12-22

iRNA Agents Targeting CCR5 Expressing Cells And Uses Thereof

#43
20110206782
2011-08-25

PIPERIDINE MODULATORS OF DOPAMINE RECEPTOR

#44
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#45
20100234604
2010-09-16

Process for Making Substituted Aryl Sulfone Intermediates

#46
20100234603
2010-09-16

Process for Making Substituted Aryl Sulfone Intermediates

#47
20100210620
2010-08-19

Substituted aryl sulfone derivatives as calcium channel blockers

#48
20100063081
2010-03-11

CPCR Agonists

#49
20100029650
2010-02-04

Bicyclic compounds and use as antidiabetics

#50
20090118332
2009-05-07

Therapeutic Agents - 551

#51
20080255345
2008-10-16

IRNA agents targeting CCR5 expressing cells and uses thereof

#52
20080234321
2008-09-25

3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission

#53
20080090828
2008-04-17

N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines

#54
20080021038
2008-01-24

Novel Piperidine/8-Azabicyclo [3.2.1.] Octan Derivatives As Modulators Of Chemokine Receptor Ccr5

#55
20070293495
2007-12-20

BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS

#56
20070270404
2007-11-22

Tuberculosis treatment using pleuromutilin derivatives

#57
20070254918
2007-11-01

Dopamine-, norepinephrine- and serotonin-transporter-selective heterocyclic compounds and their therapeutic applications

#58
20070238879
2007-10-11

Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-N-propyl-piperidine

#59
20070238878
2007-10-11

PROCESS FOR THE SYNTHESIS OF 4-(3-SULFONYLPHENYL)-PIPERIDINES

#60
20070179185
2007-08-02

Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission

#61
20060205769
2006-09-14

Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity

#62
20060189650
2006-08-24

Novel piperidine derivatives as modulators of chemokine receptor ccr5

#63
20060166962
2006-07-27

N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines

#64
20060135531
2006-06-22

Modulators of dopamine neurotransmission

#65
20060135504
2006-06-22

N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines

#66
20060116354
2006-06-01

Antineoplastic ether lipid compounds with modifications at the sn-3 carbon

#67
20060100242
2006-05-11

4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors

#68
20060074247
2006-04-06

N-protected/N-substituted-beta-amino hydroxy sulfonates

#69
20060004062
2006-01-05

Compounds for inhibiting insulin secretion and methods related thereto

#70
20050282872
2005-12-22

Thyroid receptor ligands and method II

#71
20050234109
2005-10-20

β-amyloid protein production/secretion inhibitor

#72
20050215637
2005-09-29

Tuberculosis treatment

#73
20050065140
2005-03-24

Serotonine reuptake inhibitor

#74
20050059712
2005-03-17

Acylsulfonamides as inhibitors of steroid sulfatase